Experimental and Clinical Pharmacology: Dopamine: clinical applications iii. Cardiovascular
نویسندگان
چکیده
منابع مشابه
Pharmacology, Clinical and Experimental
This book, written by Meyer and Gottlieb, professors of pharmacology at Vienna and Heidelberg, respectively, has been translated into English by Halsey, professor of pharmacology and clinical medicine at Tulane. It deals with " scientific drug therapy" and confines itself to that portion of pharmacology which should aid the physician in practising his profession. Medicinal substances are dealt ...
متن کاملClinical & Experimental Pharmacology
Objectives: Atherosclerosis is a disease process involving the early deposition of lipids in the vessel wall trapped by modified proteoglycans and subsequently a chronic inflammatory process leading to the clinical events. MTX has been chosen to study the potential efficacy of an anti inflammatory agent in preventing atherosclerosis and secondary cardiovascular disease in the cardiovascular inf...
متن کاملClinical & Experimental Pharmacology
Objectives: The aim of this study was to investigate linear and nonlinear properties of tremor time series. To this end, we applied linear (second order) and nonlinear (higher order) spectral and cross-spectral analysis to 58 Electroencephalographic (EEG) and Electromyographic (EMG) tremor recordings of seven essential and five Parkinsonian Tremor patients. Methods: Second and third order spect...
متن کاملAspirin: Pharmacology and Clinical Applications
Antiplatelet therapy has been documented to reduce risks of cardiovascular disease after acute myocardial infarction, coronary artery bypass graft, and in chronic atrial fibrillation patients, amongst other risk factors. Conventional management of thrombosis-based disorders includes the use of heparin, oral anticoagulants, and the preferred antiplatelet agent aspirin. Interestingly, aspirin was...
متن کاملClinical Pharmacology and Cardiovascular Safety of Naproxen
The voluntary withdrawal of Vioxx (rofecoxib) from the market in 2004, as well as the 2005 and 2014 US FDA Advisory Committee meetings about non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk, have raised questions surrounding the use of NSAIDs in at-risk populations. This paper discusses the cardiovascular safety profile of naproxen in the context of the NSAID class. The ba...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 1994
ISSN: 0312-8008,1839-3942
DOI: 10.18773/austprescr.1994.050